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Bovine NK cells have recently been characterized and the present study describes the interaction between
NK cells, antigen-presenting cells, and secreted mycobacterial proteins. Gamma interferon (IFN-) production
by NK cells was seen in approximately 30% of noninfected calves in response to the Mycobacterium tuberculosis
complex-specific protein ESAT-6, MPP14 from Mycobacterium avium subsp. paratuberculosis, and purified
protein derivative (PPD) from M. tuberculosis. In contrast, no response was induced by MPB70, which is
another M. tuberculosis complex-specific secreted antigen. The production of IFN- by NK cells in whole blood
in response to ESAT-6 and MPP14 was demonstrated using intracellular staining together with surface
labeling for the NK cell-specific receptor, NKp46, or CD3. Furthermore, the depletion of NK cells from
peripheral blood mononuclear cells completely abolished the IFN- production. The response was mediated
through stimulation of adherent cells and was largely independent of contact between adherent cells and the
NK cells. Neutralization of interleukin-12 only partly inhibited IFN- production, showing that other cytokines
were also involved. The demonstration of NK cell-mediated IFN- production in young cattle provides an
explanation for the nonspecific IFN- response frequently encountered in young cattle when using the IFN-
test in diagnosis of mycobacterial infections.
Mycobacterial infections are widespread in ruminants and
considered of major significance. The most important of these
is bovine tuberculosis caused by Mycobacterium bovis, which
has large economic implications and is a threat to human
health in many parts of the developing world. Another wide-
spread mycobacterial pathogen is Mycobacterium avium subsp.
paratuberculosis. This bacterium causes paratuberculosis in ru-
minants and has been linked to Crohn’s disease in humans (5).
Although conclusive evidence for the role of M. avium subsp.
paratuberculosis in Crohn’s disease is lacking, the increased
public focus on food-borne pathogens has given a renewed
interest in this bacterium.
Both M. avium subsp. paratuberculosis and M. bovis are in-
tracellular bacteria that survive and replicate inside host cells
and they elicit immune responses with similar characteristics.
The outcome of the infection is dependent on a complex in-
terplay between the invading bacteria and the immune re-
sponses of the host. Protective immunity is dependent on ac-
tivation of the cellular immune response with the production
of the Th1 cytokine gamma interferon (IFN-), which is es-
sential for resistance to mycobacteria (8, 16). The steering of
the immune response onto a Th1 pathway is dependent on
cytokines produced by the innate immune system. A key cyto-
kine in this context is interleukin-12 (IL-12), which is essential
for the development of a protective Th1 response. The impor-
tance of this cytokine has been demonstrated in humans, where
disruption of IL-12 or IL-12 receptors gives an increased sus-
ceptibility to mycobacterial infections (1, 8, 10, 11). IL-12 also
acts in synergy with IL-18 and several studies have demon-
strated that monocytes/macrophages infected with mycobacte-
ria secreted IL-12 and IL-18 (15, 17). There may however be a
distinct difference in the ability of the antigen-presenting cells
to induce IL-12 and IL-18 production (18). Hope et al. have
shown that bovine dendritic cells infected with virulent M.
bovis and M. bovis BCG produced IL-12, tumor necrosis factor
alpha, and little IL-10, whereas macrophages produced tumor
necrosis factor alpha, IL-10, and little IL-12 (22).
IL-12 and IL-18 also have a synergistic effect on IFN-
production from NK cells, which are large granular lympho-
cytes belonging to the innate immune system (17). Several
studies have shown that NK cells respond to mycobacterial
infections but they are not believed to be essential for protec-
tion (24). Nevertheless, NK cells are likely to play a role in
immune modulation and initiation of a Th1 pathway. The
findings of Vankayalapati et al. supported a role for NK cells
as a link between the innate and adapted immune response
when they demonstrated that human NK cells regulated CD8
T-cell effector function in response to Mycobacterium tubercu-
losis (42). A direct effect of mycobacteria on NK cells was also
recently described by Esin et al. (14). They demonstrated that
NK cells responded to extracellular BCG with proliferation,
IFN- production, and cytotoxicity. Similar results has been
reported in the bovine model where NK-like cells from naı¨ve
calves produced IFN- in response to M. bovis BCG-infected
dendritic cells (21).
The ability of NK cells to produce large amounts of IFN-
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may also be important for diagnostic testing. IFN- is secreted
at an early stage of mycobacterial infections and a commercial
IFN- test using purified protein derivative (PPD) is available
for bovine tuberculosis (37, 45). The rationale for measuring
IFN- production as a diagnostic parameter is that previously
sensitized T cells, through the T-cell receptor/major histocom-
patibility complex, will recognize antigens specific for one par-
ticular infection. Several groups have thus, for the last decade,
successfully focused on the use of more specific antigens such
as ESAT-6, CFP10, and MPB70 to increase the specificity of
the IFN- test (4, 36, 43). However, it is well recognized that
the test cannot be used in young cattle due to a large propor-
tion of nonspecific reactors, which display high IFN- re-
sponses but are not infected (6, 23, 27).
We believed that the IFN- responses encountered in these
young calves were not due to sensitization to other mycobac-
teria but rather caused by other mechanisms. This was sup-
ported by our previous study demonstrating that innate IFN-
production occurred in young cattle after stimulation with
MPP14, a secreted protein detected in the M. avium complex
(33, 34). We hypothesized that NK cells were responsible for
the observed IFN- production. Further characterization of
the mechanisms and cells involved in the innate IFN- pro-
duction is now feasible due to the recent characterization of
bovine NK cells and the availability of a monoclonal antibody
raised against the NK receptor NKp46 (38, 39). The aim of the
present study was to investigate the interaction between NK
cells, antigen-presenting cells, and secreted mycobacterial an-
tigens, and we identified NK cells as the prime IFN--produc-
ing cell in response to MPP14, ESAT-6, and PPD in uninfected
animals.
MATERIALS AND METHODS
Antigens. A 14-kDa secreted antigen (MPP14) was purified from M. avium
subsp. paratuberculosis as described previously (33). Purified protein derivative
(PPD) from M. tuberculosis was obtained from the National Veterinary Institute,
Oslo, Norway. Recombinant ESAT-6 produced in Escherichia coli and Lacto-
coccus lactis, respectively, were kindly provided by John Pollock, Veterinary
Science Division, Stormont, Belfast, and Peter Andersen, Statens Serum Insti-
tute, Copenhagen. The first batch was used for the initial screening of IFN-
responses in calves, while the latter batch was used throughout the rest of the
study. The two ESAT-6 batches were tested in parallel on several samples and
showed a similar response in all animals. Native MPB70 was purified as de-
scribed (31) and was provided from Morten Harboe, National Hospital, Oslo.
MPP14, ESAT-6, and MPB70 were used at a concentration of 2 g/ml and PPD
was used at a concentration at 10 g/ml.
Animals. Clinically healthy Norwegian Red dairy cattle in areas free from
paratuberculosis and bovine tuberculosis were used in the present study.
IFN- production in whole blood. Heparinized whole blood was dispensed into
24-well tissue culture trays (1 ml/well) and stimulated with purified MPP14,
ESAT-6, MPB70, and PPD and incubated at 37°C in 5% CO2 in air for 24 h. One
well served as an unstimulated control. The plasma was removed and assayed for
IFN- using the bovine IFN- enzyme-linked immunosorbent assay (ELISA)
(Bovine IFN- EASIA, Biosource, Nivelles, Belgium) according to the manu-
facturer’s instructions. Results were calculated as corrected optical density (OD):
[(mean of antigen-stimulated wells  mean of control wells)/(test positive con-
trol test negative control)]. A corrected OD above 0.3 was considered positive.
Polymyxin B (Sigma Chemical Co., St. Louis, MO), at a concentration of 50
g/ml, was added in parallel on some occasions to test for lipopolysaccharide
contamination in antigen preparations.
Depletion of NK cells. Peripheral blood mononuclear cells (PBMC) were
isolated from EDTA blood by density gradient centrifugation (1,150 g, 20 min)
on Lymphoprep (Nycomed Pharma, Oslo, Norway). NK cells were removed
using the MACS system with an LD column (Miltenyi Biotec Ltd., Bisley, United
Kingdom). In short, PBMC were incubated with monoclonal antibodies against
NKp46 (AKS1) (38) followed by anti mouse immunoglobulin G-coupled mag-
netic particles (Miltenyi Biotec). PBMC and the NK-depleted PBMC (4  105
cells/well) were cultivated in RPMI 1640 containing 10% fetal calf serum with
L-glutamine and gentamicin. The efficacy of the NK cell depletion was analyzed
on a FACScalibur flow cytometer (Becton Dickinson, NJ), equipped with Cell-
Quest software. The cells were stimulated with MPP14, ESAT-6, PPD, or me-
dium alone in 96-well flat-bottomed microculture plates and incubated at 37°C in
5% CO2 in air for 24 h. The supernatant was assayed for IFN- (Biosource) and
a standard curve was made using purified bovine IFN-, kindly provided by
Stephen Jones, Pfizer, Melbourne.
Isolation and stimulation of adherent cells. PBMC were purified as described
above and diluted in RPMI 1640 (3  106 cells/ml). Adherent cells were isolated
from PBMC in 24-well culture plates (1 ml/well) by incubation for 1 h at 37°C.
Nonadherent cells were carefully removed by rinsing at least three times with
RPMI. The adherent cells were incubated for 24 h with MPP14, ESAT-6,
MPB70, PPD, or medium alone in 500 l RPMI 1640 (5% fetal calf serum,
L-glutamine, and gentamicin). The supernatant was filtered through 0.2-m
filters (Millipore) to remove remaining cells and frozen until used for stimulation
of NK cell cultures. Polymyxin B (50 g/ml) was added in parallels to test for
lipopolysaccharide contamination in antigen preparations.
Intracellular staining for IFN-. We incubated 5 ml heparinized whole blood
with PPD, MPP14, ESAT-6, or recombinant bovine IL-2 (rbIL-2) (100 units/ml)
and rbIL-12 (5 units/ml) (20) for 24 h. Nonstimulated control cultures and
positive control cultures stimulated with 50 g/ml phorbol 12-myristate 13-
acetate (Sigma Chemical Co., St. Louis, MO) and 1 g/ml calcium ionophore
A23187 (Sigma) were included. After 6 h of incubation, 10 g/ml brefeldin A
(Sigma) was added and samples were incubated for another 12 h. PBMC were
separated on Lymphoprep as described above. Cells were washed twice in Hanks’
balanced salt solution (GibcoBRL, Paisley, United Kingdom), and 106 cells were
added to the wells of 96-well staining trays (Falcon, Becton Dickinson). Between
the following steps the cells were washed twice in phosphate-buffered saline plus
1% bovine serum albumin plus 0.05% sodium azide.
The cells were labeled for surface markers at previous determined optimal
final concentrations; NKp46 (AKS1) or CD3 (MM1A, VMRD, Pullman, Wash).
Cell suspensions were incubated with monoclonal antibodies for 30 min on ice
followed by incubation with fluorescein isothiocyanate-conjugated secondary
antibodies (10 g/ml, Southern Biotechnology Associates Inc, Birmingham, Ala)
for 30 min on ice. The cells were then fixed and permeabilized by incubating for
20 min on ice in 125 l Cytofix/Cytoperm solution (Pharmingen, San Diego, CA),
washed twice with 200 l Perm/Wash solution (Pharmingen), which was also
used for antibody diluent and washing through the rest of the procedure.
The cells were incubated for 30 min on ice with an in-house monoclonal
antibody (immunoglobulin G2a clone 6.19) raised against affinity-purified bovine
IFN-, washed twice, and incubated with phycoerythrin-conjugated secondary
antibody (5 g/ml, Southern), followed by another wash and resuspension in 400
l fluorescence-activated cell sorting buffer (Becton Dickinson). The samples
were analyzed on a FACScalibur flow cytometer (Becton Dickinson), equipped
with Cell-Quest software; 100,000 lymphocytes were read using forward and side
scatter gating. Gates for identifying NKp46- and CD3-positive cells were set
using cells stained with secondary antibodies only.
NK cell cultures and stimulations. rbIL-2 activated NK cell cultures were
established as previously described (38) Briefly, monoclonal antibody against
NKp46 (AKS1) was incubated with PBMC isolated on Lymphoprep, and NKp46-
positive cells were selected by incubation with anti mouse immunoglobulin G-
coated Dynabeads (Dynal, Oslo, Norway) and magnetic separation. Positively
selected cells were cultured in RPMI 1640 supplemented with 60 g/ml penicil-
lin, 100 g/ml streptomycin, 1 mM sodium pyruvate, nonessential amino acids, 50
M 2-mercaptoethanol (all Invitrogen, Carlsbad, Ca), 10% fetal calf serum, and
100 biological units/ml rbIL-2 (medium). Proliferating NK cells were used after
7 to 14 days of culture.
NK cells were washed in medium without rbIL-2, diluted to a concentration of
2  10 6 cells/ml and added to wells of 96-well cell culture trays containing
different stimulators. The final cell concentration was 106 cells/ml and stimula-
tions were set up in triplicates. The supernatants from antigen stimulated ad-
herent cells were used at a final dilution of 1/10. rbIL-12 was used at various
concentrations as indicated and anti-IL-12 (clone cc301) (20) was used at a
concentration of 10 g/ml in neutralizing experiments.
Statistics. The differences in responses to the various antigens were evaluated
using the nonparametric Wilcoxon-Mann-Whitney test. P  0.05 was considered
significant.
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RESULTS
IFN- production in response to secreted mycobacterial
proteins in young cattle. Young cattle in an area free from
bovine tuberculosis and paratuberculosis were tested for IFN-
production in response to ESAT-6, MPB70, and PPD. Clini-
cally healthy cattle (n  54) under the age of 18 months were
tested four times each within a period of 6 months using a
whole-blood assay. Altogether 31% of the animals had an
IFN- response to ESAT-6 at one or more occasions, while
37% responded to PPD. In contrast, no IFN- response was
detected in any sample stimulated with MPB70. There was also
a significant difference in the average response to ESAT-6 and
PPD compared to MPB70 (Fig. 1). To exclude the influence of
possible lipopolysaccharide contamination, polymyxin B was
added to the samples at some occasions. No inhibition of
IFN- production was observed.
The IFN- production in response to secreted mycobacterial
proteins was also followed in 14 calves from the first week of
life and up to the age of approximately 2 months. IFN- was
detected after stimulation with ESAT-6, MPP14, and PPD
from the second week after birth, while no response was seen
after stimulation with MPB70 (Fig. 2). Distinct differences
between the animals were present. Seven animals had no re-
sponses to any of the antigens, while seven animals reacted
(corrected OD  0.3) to ESAT-6, MPP14, and PPD antigens
at several occasions (Fig. 2). The animals that responded to
ESAT-6 usually also responded to MPP14 and PPD.
NK cells produce IFN- in response to mycobacterial anti-
gens. To test the hypothesis that NK cells were responsible for
the IFN- production, PBMC from responding animals were
depleted of NK cells using a monoclonal antibody directed
against NKp46, followed by secondary antibodies coupled to
magnetic beads. The removal of NK cells was monitored using
flow cytometry and routinely more than 95% of the NK cells
were removed. PBMC and PBMC depleted of NK cells were
stimulated with MPP14, ESAT-6, and PPD, and the superna-
tant was assayed for IFN- production after 24 h of stimula-
tion. The samples were stimulated in triplicate, and the assay
was repeated three times using PBMC from six different ani-
mals, and two representative examples are shown in (Fig. 3).
While the amount of IFN- produced varied from animal to
animal, the IFN- responses were always eliminated after de-
pletion of NK cells. This demonstrates that the NK cells pro-
duced IFN-, or alternatively, were necessary for IFN- pro-
duction from other cell types.
To confirm that the cells producing IFN- were indeed NK
cells, whole blood from responder animals were incubated with
ESAT-6 or MPP14 or left unstimulated. Intracellular staining
for IFN- together with labeling for surface markers and anal-
ysis by flow cytometry identified NK cells as the main IFN--
producing cell type while little IFN- was produced by CD3
cells (Fig. 4). The experiment was repeated six times, and
between 1 and 4% of the NK cells produced IFN- after
stimulation with ESAT-6 or MPP14. The relatively small num-
ber of IFN--producing NK cells is in accordance with results
from human studies where only a minor population of NK cells
produced large amounts of IFN- (7). In comparison, less than
0.3% of CD3 cells produced IFN- after stimulation with
these antigens. CD3 cells were however the major IFN-
producers after stimulation with phorbol myristate acetate and
calcium ionophore (data not shown). We also found a large
individual variation in the number of IFN--producing NK
cells in nonstimulated samples ranging from 0.1 to 3.0% while
no spontaneous IFN- production in CD3 cells was detected.
The two different methods, depletion of NK cells from PBMC
and intracellular staining, conclusively established NK cells as
a source of IFN- after stimulation with ESAT-6 and MPP14.
Antigen-induced IFN- production in NK cell cultures was
dependent on adherent cells. In an attempt to define the mech-
anism of IFN- production by NK cells, rbIL-2 activated NK
cell cultures were stimulated with MPP14 and ESAT-6. No
IFN- was detected, indicating that the antigens alone were
unable to stimulate NK cells directly (data not shown). We
thus hypothesized that the IFN- production by NK cells was
mediated through stimulation of antigen-presenting cells. Ad-
herent cells from four animals were incubated with MPP14,
ESAT-6, MPB70, PPD, and medium alone, and the superna-
tants were assayed for the ability to induce IFN- production
in nonautologous NK cell cultures. The assay was repeated
four times, and the NK cell cultures were stimulated in tripli-
cate. The results are given as the mean increase in IFN-
production in response to the various antigens compared to
medium alone.
There was a relatively large variation in IFN- production
between NK cell cultures from different animals. However, in
all the animals, supernatants from the MPP14-stimulated ad-
herent cells induced significantly higher IFN- production
compared to MPB70, while three out of four animals had a
significantly higher response to ESAT-6 compared to MPB70
(Table 1). These results indicated that MPP14 and ESAT-6
induced cytokine production in adherent cells that subse-
quently induced IFN- production by NK cells. Since activated
macrophages are able to secrete IFN-, the supernatants from
stimulated adherent cells were assayed for the presence of this
cytokine, and no IFN- was detected. Furthermore, lipopoly-
saccharide is a potent stimulator of antigen-presenting cells,
and to exclude the influence of possible lipopolysaccharide
contamination, polymyxin B was added to some of the samples.
Minimal inhibition of IFN- production was observed.
A likely mechanism for the IFN- production in NK cells in
antigen-stimulated whole blood is through cytokines from
stimulated monocytes. To see whether bovine NK cells in
FIG. 1. Extent of IFN- production in an M. bovis-free area. Young
cattle between 2 and 18 months of age (n  54) from three different
herds were tested four times for IFN- production after stimulation of
whole blood with PPD, ESAT-6, and MPB70 for 24 h. The mean
response in each animal is shown as dots, while the means for each
antigen stimulation are shown as lines. Corrected OD is expressed as
[(mean of antigen-stimulated wellsmean control wells)/(test positive
control  test negative control)].
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blood can produce IFN- in response to cytokines, heparinized
whole-blood samples were stimulated with rbIL-2 and rbIL-12.
IFN- production was subsequently measured using intracel-
lular staining and flow cytometry. An average of 10.9% of the
NK cells produced IFN-, with an individual variation ranging
from 4.9 to 20.1% (n  6) (Fig. 5A). In contrast, the average
number of CD3 cells producing IFN- was 1.3%. This
showed that a combination of rbIL-2 and rbIL-12 induced
IFN- production in NK cells in whole-blood (Fig. 5A). Like-
wise, NK cells in cultures stimulated with rbIL-2 and rbIL-12
produced IFN- (Fig. 5B), while low levels (1 to 2 ng/ml) of
IFN- were detected when rbIL-2 (25 to 200U) or rbIL-12 (2.5
to 20 U) was used alone.
Neutralization of IFN- production in NK cells was achieved
by adding anti-IL-12 antibodies (Fig. 5B). We subsequently
assessed whether IL-12 from antigen-stimulated adherent cells
was responsible for the induced IFN- production by NK cells.
The presence of IL-12 in the supernatants was estimated in an
FIG. 2. IFN- responses in 14 young calves during the first 2 months of life. Whole blood was stimulated for 24 h with MPP14, ESAT-6, and
MPB70 at a concentration of 2 g/ml and PPD at a concentration of 10 g/ml. The responders (n  7) are animals with an IFN- response
(corrected OD  0.3) at at least one time point against any of the purified antigens. Nonresponders (n  7) never had a corrected OD of 0.3
against any of the antigens. Stimulations were made with (A and B) PPD, (C and D) MPP14, (E and F) ESAT-6, or (G and H) MPB70.
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IL-12 assay as described previously (20) and small amounts of
IL-12 (1 U/ml) were detected. Anti-IL-12 was added to NK
cell cultures together with supernatant from antigen-stimu-
lated adherent cells to see if a possible effect of IL-12 could be
neutralized. The addition of anti-IL-12 antibodies gave a re-
duction of IFN- production varying from 15% to 47%, show-
ing that IL-12 was partly responsible for the observed IFN-
production from NK cells (Fig. 5C). However, other cytokines
were also likely to be involved.
DISCUSSION
The present study investigated the interaction between NK
cells, adherent cells, and secreted mycobacterial antigens. We
found that the mycobacterial antigens ESAT-6 from the M.
tuberculosis complex and MPP14 from the M. avium complex
induced IFN- production from NK cells. The response was
dependent on adherent cells and likely mediated through cy-
tokine production.
We have previously demonstrated innate IFN- production
in healthy calves in response to MPP14 (34). The recent char-
acterization of bovine NK cells and the generation of a mono-
clonal antibody raised against the bovine NK cell marker
NKp46 (38, 39) facilitated a more detailed study of this innate
IFN- production. ESAT-6, MPP14, and MPB70 are secreted
antigens available to the immune system at an early stage of
the infection, and several such proteins can induce strong
IFN- production from sensitized T cells (2, 25). In the present
study we have shown that ESAT-6 and MPP14 were able to
induce IFN- production from NK cells.
FIG. 3. IFN- production in PBMC and PBMC depleted of NK cells stimulated with mycobacterial antigens. The samples were stimulated with
MPP14 (2 g/ml), ESAT-6 (2 g/ml), or PPD (10 g/ml) for 24 h and the supernatant was assayed for IFN- production. The results are the means
of cells stimulated in triplicates 	 standard error of the mean. The experiment was repeated three times using PBMC from six different animals.
FIG. 4. Flow cytometry plots verifying IFN- production by NK
cells. Whole blood was stimulated with MPP14 or ESAT-6 or left
unstimulated for 6 h. Brefeldin A was added to stop protein export and
the samples were incubated for another 12 h. PBMC was subsequently
purified by density gradient centrifugation. The cells were labeled with
monoclonal antibodies against A) the NK cell marker NKp46 and B)
CD3, followed by permeabilization and labeling for intracellular
IFN-; 100,000 lymphocytes were analyzed and gated for NKp46-
positive and CD3 cells, respectively. Numbers in the upper right
quadrant indicate the percentages of NK cells or CD3 cells producing
IFN-.
TABLE 1. Increase in IFN- production in NK cell cultures after
stimulation with supernatant from antigen-stimulated adherent cells
compared to medium alonea
Calf
no.
Mean IFN- production (ng/ml) 	 SEM
MPP14 ESAT-6 PPD MPB70
1 1.3 	 0.1* 2.8	 0.7* 4.6	 0.8 0.4	 0.3
2 2.5 	 0.6* 1.9	 0.4* 1.8	 0.5 0.0	 0.5
3 5.0 	 0.5* 4.5	 0.5 0.8	 0.4 2.8	 0.5
4 4.8 	 1.1* 3.0	 0.8* 3.8	 1.1* 0.6	 0.2
a *, P  0.05, Wilcoxon rank test, compared to MPB70.
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NK cells are important in immune regulation and play a role
in directing the immune system towards a Th1 pathway in
other species (40, 42), however, the significance of NK cells in
cattle remains to be established. ESAT-6 and MPP14 may be
of importance in the development of a protective Th1 response
and are thus good candidates to be evaluated in new vaccines
against M. bovis and M. avium subsp. paratuberculosis. The
ability of ESAT-6 to initiate a Th1 response has been shown
previously in the mouse model, where ESAT-6 delivered as a
fusion protein and as a DNA vaccine induced IFN- produc-
tion to an unrelated antigen (29, 30). Mycobacteria are likely to
harbor antigens that induce both beneficial and detrimental
immune responses. A detailed examination of the effect of
various mycobacterial antigens on the innate and the adaptive
immune system will facilitate a rational strategy for the design
of new vaccines.
The mechanisms for the antigen-induced IFN- production
from NK cells were not fully explained. However, a definite
requirement for antigen-stimulated adherent cells was clearly
detected. Most likely, the observed IFN- production from NK
cells was a result of cytokines secreted from the adherent cells.
Despite the low levels of IL-12 present in the samples, neu-
tralization of IL-12 partly inhibited the observed IFN- pro-
duction from NK cells. It is thus likely that other cytokines
were involved, and that these cytokines acted in synergy with
IL-12. A likely candidate is IL-18. This cytokine is produced by
monocytes and macrophages and has a variety of biological
functions, including induction of type 1 cytokines and enhance-
ment of NK cell functions (12). The production of IFN- from
NK cells in response to IL-18 produced by Mycobacterium
leprae-stimulated human monocytes was demonstrated by Gar-
cia et al. (17).
The lack of antibodies to the bovine Toll-like receptors
(TLRs) and other receptors hindered detailed investigation of
the mechanisms for the interaction of ESAT-6 and MPP14
with adherent cells. The interaction of mycobacterial compo-
nents with innate immune receptors such as TLR-2 and TLR-4
have been studied in murine and human models. Lipoarabino-
mannan and its precursor lipomannan from the mycobacterial
cell wall can interact with TLR and induce production of
proinflammatory cytokines (9, 28, 41). Furthermore, lipopro-
teins from M. tuberculosis induced IL-12 production mediated
via TLR (3). In these proteins the lipid moiety was believed to
be essential for activation. Activation through TLR by protein
ligands has not been extensively investigated. However, Ohashi
et al. showed that the human heat shock protein 60 induced
tumor necrosis factor alpha and NO2
 production through
TLR-4 (32). We have here demonstrated that secreted myco-
bacterial protein antigens also can interact with the innate
immune system.
There was a remarkable individual difference in the NK cell
mediated IFN- responses. The explanation for these individ-
ual variations is unclear. Young calves will encounter numer-
ous antigens for the first time and they are likely to have a
highly activated immune system. The combination of viral,
bacterial, and parasitic agents the naı¨ve animal is exposed to,
together with inherent predisposition, may steer the general
immune response onto a Th1 or Th2 pathway. This was re-
cently demonstrated by Elias et al., who showed that Schisto-
soma mansoni infection induced a general Th2 response, and
that the S. mansoni-infected mice were less able to elicit a Th1
response than the controls (13). The infected mice had a re-
duced protective effect of BCG vaccination with a lower IFN-
production.
FIG. 5. Mechanisms for IFN- production by NK cells. A) Intra-
cellular flow cytometry staining for IFN- and surface markers in IL-2
(100 U) and IL-12 (5 U)-stimulated whole blood (100,000 gated lym-
phocytes); 4.9% of the NKp46-positive cells produced IFN-. B) IFN-
production in IL-2-activated NK cell cultures after stimulation with
IL-2 and different levels of IL-12 with or without neutralization by
anti-IL-12. C) Production of IFN- by NK cells stimulated with super-
natant from antigen-stimulated adherent cells. Supernatants from an-
tigen-stimulated adherent cells were diluted 1:10 and incubated with or
without anti-IL-12 for 1 hour before addition of NK cells. The amount
of IFN- was measured by ELISA after 24 h of incubation.
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A general activation of the immune system towards a Th1 or
Th2 pathway in the different calves may explain the individual
variations in IFN- production from NK cells. This may also be
reflected in variations in spontaneous cytokines secretion in
peripheral blood as detected in the present study, where non-
stimulated NK cells showed large variations in IFN- secre-
tion. Such variations have been observed by Walker et al. in
patients and healthy humans in Malawi, where the frequency
of mycobacterial and parasitic infections was high (44). They
also showed that spontaneous cytokine production influenced
the induced production. Donors who had spontaneous IFN-
production by NK cells also showed increased production after
stimulation with phorbol myristate acetate and calcium iono-
phore compared to donors without spontaneous IFN- pro-
duction. This is in accordance with the findings in the present
and our previous study, where animals that had innate IFN-
production in response to MPP14 also had low-level sponta-
neous IFN- production (34).
The IFN- test has been used in several countries to diag-
nose early stages of bovine tuberculosis and the use of specific
proteins such as ESAT-6 has clearly increased the specificity of
this test (4, 35). However, it is widely recognized that the test
cannot be used in young animals due to nonspecific IFN-
production (6, 27). Our results demonstrated that NK cells are
a source of innate IFN- production, and this provides an
explanation for the problems encountered in the young calves.
This is also in agreement with the finding that young calves had
the highest proportion of NK cells in peripheral blood (26).
In a broader screening of IFN- production in young cattle,
we found that approximately one third of the animals under
the age of 18 months produced IFN- in response to ESAT-6
and that calves responding to ESAT-6 also usually responded
to MPP14. ESAT-6 is present in the M tuberculosis complex
and has also been detected in M. kansasii and M. flavescens
(19), while MPP14 was detected by Western blotting in the M.
avium complex and M. scrofulaceum (33). It is unlikely that as
many as one-third of the animals were sensitized to mycobac-
teria harboring both MPP14 and ESAT-6. Consequently, it is
likely that NK cells are responsible for the majority of the
nonspecific IFN- production observed in young cattle. Meth-
ods that inhibit IFN- production from NK cells would there-
fore lead to an improvement of the IFN- test for detection of
bovine mycobacterial diseases.
In conclusion, we have demonstrated that IFN- production
from NK cells occurred in response to adherent cells stimu-
lated with the secreted proteins ESAT-6 and MPP14. This will
have consequences for the interpretation and use of the IFN-
test for diagnosis of mycobacterial infections in young cattle.
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